Marimed Expects To Lead In Hemp Derived CBD Following 2018 Farm Bill Passage
Originally appeared in the Market Exclusive written by ME Staff.
4 Under-the-Radar Marijuana Stocks That Benefit if New Jersey Legalizes Recreational Pot
This article originally appeared in The Motley Fool written by Sean Williams.
3 Top U.S. Marijuana Stocks of 2018 — Are They Buys?
2. MariMed Halfway through 2018, MariMed already ranked as the top-performing marijuana stock of all. Its winning ways continued in the second half of the year despite a marked decline over the last couple of months. MariMed is set to finish 2018 up more than 300%.
MariMed Inc (OTCMKTS:MRMD) Is All Set To Maintain Leadership Position in Hemp CBD with Eminent Signing of the US Farm Bill 2018
Article originally appeared in MMJ Reporter written by Chris Stewart
The Bay State’s Biggest Stock Gainer in 2018 is a Marijuana Company
Originally appeared in the Boston Business Journal written by Don Seiffert.
The Marimed Inc Outperformance Story Remains Intact
Originally appeared in Oracle Dispatch written by James Hudson
MariMed Inc. Gross Margin of 50.00000 Grasps Investor’s Attention
Originally appeared in Canton Caller written by a staff writer
7 U.S. Marijuana Stocks to Buy for the Midterm Elections
Originally appeared in Investor Place written by Josh Enomoto Marimed (MRMD) Whenever you’re dealing with pot stocks, it’s difficult to filter hype from reality. While I broadly consider the sector a paradigm-shattering opportunity, whenever money is involved, hucksters quickly follow. That’s why I appreciate what Marimed(OTCMKTS:MRMD) has to offer.
3 Best Marijuana Stocks of 2018 So Far — Are They Buys Now?
Originally appeared in Yahoo Finance written by Keith Speights at the Motley Fool.
So Far, This Is the Best Performing Marijuana Stock Of 2018
Originally appeared in The Fresh Toast written by Mary Schumacher
Recent Posts
December 1, 2022
Leafly: Nature's Heritage Included in Holiday Gift Guide
November 18, 2022
High Times: MariMed Donates Turkeys For Thanksgiving
November 1, 2022
CSE Magazine: MariMed is a Company to Watch